Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Alto Neuroscience (ANRO) Other Gross PP&E Adjustments (2023 - 2026)

Alto Neuroscience has reported Other Gross PP&E Adjustments over the past 4 years, most recently at -$3.5 million for Q1 2026.

  • Quarterly results put Other Gross PP&E Adjustments at -$3.5 million for Q1 2026, down 35.0% from a year ago — trailing twelve months through Mar 2026 was -$3.5 million (down 35.0% YoY), and the annual figure for FY2025 was -$7.4 million, down 13.32%.
  • Other Gross PP&E Adjustments reached -$3.5 million in Q1 2026 per ANRO's latest filing, up from -$7.4 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $1.7 million in Q1 2024 and bottomed at -$7.4 million in Q4 2025.
  • Median Other Gross PP&E Adjustments over the past 4 years was -$3.0 million (2025), compared with a mean of -$2.8 million.
  • The largest annual shift saw Other Gross PP&E Adjustments tumbled 843.99% in 2024 before it increased 18.71% in 2025.
  • Over 4 years, Other Gross PP&E Adjustments stood at $882000.0 in 2023, then crashed by 843.99% to -$6.6 million in 2024, then decreased by 13.32% to -$7.4 million in 2025, then skyrocketed by 53.11% to -$3.5 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for ANRO at -$3.5 million in Q1 2026, -$7.4 million in Q4 2025, and -$3.9 million in Q3 2025.